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Role of caspases (ICE/CED 3 proteases) in DNA damage and cell death
in response to a mitochondrial inhibitor, antimycin A. Caspases (ICE!
Ced3 proteases) are a closely related family of cysteine proteases that play
a key role in apoptotic cell death. We examined the role of caspases in
DNA damage and cell death in response to the mitochondrial inhibitor,
antimycin A. LLC-PK1 cells contain caspase activity that was markedly
inhibited by cleavage site-based peptide inhibitors of caspases but not by
inhibitors of serine, cysteine, aspartate or metalloproteinases. The caspase
activity increased within five minutes of exposure to antimycin A, preced-
ing any evidence of DNA damage and cell death. The specific caspase
inhibitors, Ac-Tyr-Val-Ala-Asp-aldehyde (inhibitor I) and Ac-Asp-Glu-
Val-Asp-aldehyde (inhibitor II) prevented, in a dose dependent manner,
antimycin A-induced DNA strand breaks as determined by DNA unwind-
ing assay (residual double stranded DNA in control, 94 2%; antimycin
A alone, 48 3%; antimycin A + inhibitor I at 50 jzM, 93 2%; antimycin
A + inhibitor II at 50 M, 89 5%; N = 3 to 4, P < 0.001). These
inhibitors also prevented antimycin A-induced DNA fragmentation as
determined by agarose gel electrophoresis and by in situ labeling of cell
nuclei by the terminal deoxynucleotidyl transferase (TdT) nick end
labeling (TUNEL) method. The caspase inhibitors markedly prevented
antimycin A-induced cell death in a dose-dependent manner as measured
by trypan blue exclusion (control 6 1%, antimycin A alone 40 1%,
antimycin A + inhibitor I at 50 jM 16 1%, antimycin A + inhibitor II
at 50 zM 16 1%; N = 4 to 7, P < 0.001). These data indicate that the
caspase family of enzymes play an important role in DNA damage and cell
death in response to the mitochondrial inhibitor, antimycin A.
Interleukin 1 /3-converting enzyme (ICE) and its family of
proteases (ICE-like) have been identified as a group of closely
related cysteine proteases involved in apoptosis [1—5]. Recently
the trivial name "caspase" has been suggested as the root for
serial names for all family members of ICE/Ced-3 proteases [6].
The selection of the name "caspase" includes two distinct catalytic
properties of these enzymes such that "c" refers to the cysteine
protease mechanisms and "aspase" refers to their specific ability
to cleave after aspartic acid [6]. The initial evidence implicating
the role of caspases in cell death came from studies that demon-
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strated significant sequence homology of these proteases with the
cell death gene, ced3, encoding a programmed cell death protein
in C. elegans [7]. Several members of Ced3!ICE-related family of
cysteine proteases have been characterized and shown to play a
critical role in apoptotic pathways in mammalian cell lines [1—5].
When transfected to recipient cells, these proteases result in
characteristic features of apoptotic cell death including cell
shrinkage, chromatin condensation and internucleosomal DNA
fragmentation.
Although internucleosomal DNA fragmentation resulting from
endonuclease activation is generally considered to be a feature of
apoptosis, recent studies have demonstrated that this biochemical
feature occurs in cell death traditionally considered a necrotic
form of cell death. Thus, in several in vivo studies of renal
ischemia/reperfusion injury, DNA fragmentation in the kidney
cortex [8—101 and other tissues [11—14] has been demonstrated. In
addition to these in vivo studies, we have demonstrated that
freshly isolated tubules subjected to hypoxia/reoxygenation results
in DNA strand breaks and nuclear DNA fragmentation (both by
an in situ technique and by agarose gel electrophoresis), which
precedes cell death. Endonuclease inhibitors provided complete
protection against DNA damage induced by hypoxia/reoxygen-
ation and partial protection against cell death [15].
Ischemia involves cessation of both exogenous substrate deliv-
ery and lack of oxygen, however, its most defining feature is lack
of oxygen for ATP synthesis. Thus, metabolic inhibitors of mito-
chondrial respiratory chain that induce severe ATP depletion
characteristic of ischemia have been extensively utilized to study
hypoxic injury [16—18], and results in a necrotic form of cell death
[16]. In our previous study we demonstrated that this model of
chemical hypoxia in LLC-PK1 cells resulted in multiples of low
molecular weight DNA fragments [18] characteristic of endonu-
clease activation and similar to the findings described above.
Similarly, Iwata et al [9] have shown that in hypoxic injury, DNA
fragmentation was associated with morphological features of
necrosis.
There is no information on the role of caspase proteases in
hypoxia-induced DNA damage in any tissue and only a single
recent report on their role in hypoxia-induced cell death in
neuronal cells [19]. In the present study we first analyzed the
caspase activity in antimycin A-induced injury to LLC-PK1 cells,
and then evaluated DNA strand breaks and DNA fragmentation
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in the presence and absence of inhibitors of caspases. Further, we
determined the effect of these inhibitors on antimycin A-induced
cell death.
METHODS
Cell culture
LLC-PK1 cells obtained from American Type Culture Collec-
tion were cultured as in our previous studies [20]. The cells were
grown in Dulbecco's modified Eagle's medium (DMEM) supple-
mented with 10% heat-inactivated fetal calf serum, 2 ms'i L-
glutamine, 20 mrvi 4-(2-hydroxy ethyl)-l-piperazine ethanesulfonic
acid (HEPES) and 2 m nonessential amino acids. Cultures were
maintained in a humidified incubator gassed with 5% C02—95%
air at 37°C and fed with fresh medium at intervals of 48 to 72
hours. Experiments were performed with cells grown to one to
two days postconfluence.
Induction of chemical hypoxia
Chemical hypoxia was induced using a combination of glucose
deprivation and mitochondrial electron transport inhibition as
previously described [16, 18]. After confluency, cells were washed
and incubated with DMEM without serum, glutamine, pyruvate,
nonessential amino acids or glucose, containing 3.7 g/liter
NaHCO3 and 20 msi HEPES at pH 7.4, either with or without
antimycin A for the period of time indicated. In initial studies
we determined the optimum exposure time and the suitable
concentration of antimycin A. To determine a role of caspases
in DNA damage and cell death induced by antimycin A, cells
were preincubated with caspase inhibitor I (Ac-Tyr-Val-Ala-Asp-
aldehyde, YVAD-CHO) and inhibitor II (Ac-Asp-Glu-Val-Asp-
aldehyde, DEVD-CHO) (Bachem Inc., CA, USA, for inhibitors
I and II) for 60 minutes, washed and exposed to antimycin A
(10 LM). These tetrapeptide inhibitors based on the cleavage
sequence irreversibly inhibit select members of the caspase family
[21, 22].
Determination of DNA damage
The residual double strand DNA was measured by the alkaline
unwinding assay and determination of ethidium bromide fluores-
cence according to the method of Birnboim and Jevcak [24], as
utilized in our previous studies [15, 18, 20]. Ethidium bromide
fluorescence was measured at 520 nm excitation and 590 nm
emission using a fluorescence spectrophotometer. Under the
conditions employed, ethidium bromide binds preferentially to
double strand DNA. Percent double strand DNA (D) was deter-
mined by the equation: %D = 100 X [F(P) — F(B)]I[F(T) —
F(B)], where F(P) is the sample fluorescence, F(T) is the total
fluorescence prior to alkaline treatment, and F(B) is the back-
ground fluorescence that was obtained from sonicated, alkaline-
treated DNA, a condition under which the DNA is completely
unwound and represents the fluorescence due to all components
other than double stranded DNA.
Detection of DNA fragmentation by agarose gel electrophoresis
Fragmented DNA was isolated from LLC-PK1 cells as previ-
ously described [15, 18, 20, 25]. Cells were collected by centrifu-
gation at 200 g for 10 minutes and the pellets were lysed with 1.0
ml of lysis buffer containing 0.5% Triton X-100, 10 mM Tris-HC1,
pH 8.0, 25 mM EDTA for one to two hours at 4°C. The lysates
were centrifuged at 16,000 g for 20 minutes to separate the
fragmented DNA (supernatant) from the intact DNA (pellet).
The resulting supernatant containing fragmented DNA was incu-
bated with proteinase K (200 g/ml) at 50°C overnight. The DNA
was extracted with phenol-chioroform-isoamyl alcohol (50:49:1),
followed by precipitation with 0.1 vol of 3 M sodium acetate and
2.5 vol of 100% ethanol. The concentration of nucleic acid in each
sample was determined by UV absorbance at 260 nm. The same
amount of nucleic acid from each sample was treated with RNAse
(20 jig/mI) at 37°C for three hours and subjected to electrophore-
sis on 1% agarose gel. After electrophoresis the DNA was
visualized by UV fluorescence after staining with ethidium bro-
mide.
Determination of caspase activity
Cells were harvested by centrifugation and the pellets were
homogenized with 20 ms HEPES, pH 7.5, containing 10%
sucrose, 0.1% CHAPS, 2 mi DII, 0.1% NP4O, 1 mM EDTA, I
mM PMSF, 1 jig/mI leupeptin and 1 jig/mI pepstatin A. The
supernatants obtained after centrifugation were used to deter-
mine the enzyme activity. The caspase activity was determined by
fluorometric assay using the substrate, Ac-Tyr-Val-Ala-Asp-
AMC, which is specifically cleaved by the enzyme to release the
fluorescent leaving group, amino-4-methyl coumarin (AMC) [23].
The appropriate amounts of enzyme extracts were incubated with
100 mM HEPES, pH 7.5, containing 10% sucrose, 0.1% CHAPS,
10 mM DII and 14 j.LM substrate in a total reaction volume of 0.5
ml. The reaction mixture was incubated for 30 minutes at 25°C. At
the end of incubation, the liberated fluorescent group was moni-
tored continuously using a spectrofluorometer (Perkin Elmer)
with an excitation wavelength of 380 nm and an emission wave-
length of 460 nm. AMC was used as a standard. One unit of
enzyme activity is defined as the amount of enzyme required to
liberate 2 n of AMC in 30 minutes. The data for caspase activity
are expressed as U/mg protein.
In situ detection of DNA fragmentation
The terminal deoxynucleotidyl transferase (TdT) nick end
labeling (TUNEL) technique was used to detect in situ DNA
strand breaks as described [26]. Cells were grown to confluency on
two-chamber tissue culture slides. Cells were exposed to antimy-
cm A in the absence or presence of caspases inhibitors as
described. At the end of the experiment, the cells were fixed in 4%
paraformaldehyde and then treated with 1% H202 in PBS for 10
minutes to remove endogenous peroxidase activity. Following
labeling with digoxigenin-labeled nucleotides the cells were
treated with peroxidase conjugated anti-digoxigenin antibody and
stained with peroxide substrate using the in situ ApopTag Plus
labeling method (Oncor).
Determination of cell injury and cellular ATP
Cell viability was determined using trypan blue exclusion [27].
Cellular ATP was measured by luciferin/luciferase assay as previ-
ously described [16, 17].
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Statistics
Results are mean SE. Statistical significance was determined
by the Student's 1-test. A P value less than 0.05 was considered to
be significant.
RESULTS
We first examined the presence of caspase activity (ICE/Ced3
proteases) in LLC-PK cells. The caspase activity was determined
using fluorometric peptide substrate, Ac-Tyr-Val-Ala-Asp-AMC,
containing the specific aspartic acid cleavage site for caspase
proteases. LLC-PK1 cells contain caspase activity that is directly
proportional to both protein concentration and time of incubation
(Fig. 1). This activity is not inhibited by inhibitors of serine
proteases (PMSF, aprotinin, SBTI), aspartic proteases (pepstatin
A) and metalloproteinases (EDTA, 1,10-phenanthroline) (Table
1). Although ICE and ICE-like proteases are classified under
cysteine proteases because of the presence of cysteine in the
catalytic site, cysteine protease inhibitors including leupeptin,
E-64, E64d and specific calpain peptide inhibitor did not inhibit
caspase activity (Table 1). In contrast, specific and competitive
tetrapeptide inhibitors of caspase, Ac-Tyr-Val-Ala-Asp-aldehyde
(inhibitor I, YVAD-CHO) and Ac-Asp-Glu-Val-Asp-aldehyde
(inhibitor II, DEVD-CHO), which are based on the cleavage site
aspartic acid and other amino acids required to the left of the
cleavage site, markedly inhibited caspase activity (Fig. 2). The use
of the specific substrate, lack of inhibition of the activity by other
protease inhibitors, and marked inhibition by the caspase inhibi-
tors confirmed the presence of caspase activity in LLC-PK1 cells
and validated the assay utilized for the measurement of the
activity.
Caspase activity was increased within five minutes exposure of
antimycin A to cells and returned to baseline at longer periods
(Fig. 3). We have previously shown that DNA damage in LLC-
PK1 cells occurs in 30 minutes whereas cell death occurs in two
hours after antimycin A-induced injury [18]. Taken together,
these data indicate that chemical hypoxia-induced increase in
caspase activity preceded any evidence of DNA damage and cell
death.
We next examined the role of caspase in antimycin A-induced
DNA damage utilizing caspase inhibitor I and inhibitor II. LLC-
PK1 cells exposed to 10 M antimycin A concentration caused
marked DNA strand breaks (measured by the alkaline unwinding
assay) as shown in Figure 4 and as reported in our previous studies
[18]. The caspase inhibitors prevented antimycin A-induced DNA
strand breaks in a dose-dependent manner (Fig. 4A). At 50 LM
concentration, these inhibitors provided significant protection
against antimycin A-induced DNA strand breaks (residual double
stranded DNA in control, 94 2%; antimycin A alone, 48 3%;
antimycin A + inhibitor I, 93 2%; antimycin A + inhibitor II,
89 5%; N = 4, P < 0.001, Fig. 4B). Exposure of cells to
antimycin A resulted in multiples of low molecular weight DNA
fragments as determined by agarose gel electrophoresis (Fig. 5),
and as shown in our previous studies [18]. The inhibition of
caspase activity provided marked protection against antimycin
A-induced DNA fragmentation (Fig. 5). We also examined the
effect of caspase inhibitors I and II on antimycin A-induced DNA
damage by in situ in cell nuclei utilizing the TUNEL technique. As
shown in Figure 6, a significant number of nuclei of antimycin A
treated cells were positively stained for DNA strand breaks
compared to the corresponding controls that showed no detect-
able in situ DNA nick-end labeling. In cells exposed to antimycin
A, the morphology of the cell nuclei showing positive staining
(brown) for DNA strand breaks was relatively preserved (Fig. 6).
The cells treated with the caspase inhibitors did not show distinct
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Fig. 1. Protein dependence and time course of caspase activity. (A)
Various amounts of cell extracts were incubated in an assay mixture
containing fluorometric substrate, Ac-Tyr-Val-Ala-Asp-AMC (14 tiM), 20
mM HEPES, pH 7.5, containing 10% sucrose, 0.1% CHAPS, 2 mM DTF,
0.1% NP4O, 1 mM EDTA, 1 mrvi PMSF, 1 gig/mI leupeptin and 1 Lg/mI
pepstatin A in a total volume of 0.5 ml for 30 minutes at 25°C. At the end
of incubation, the liberated AMC was determined using a spectrofluorom-
eter with an excitation wavelength of 380 nm and an emission wavelength
of 460 nm. Results are mean SEM, N = 4. (B) Cell extract (300 gg) was
added to assay mixture and incubated for various times shown. The values
are an average of two determinations.
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Inhibitor Concentration
Enzyme activity
% of control
PMSF 0.5 mst 100 2
Aprotinin 10 ig/m1 101 2
SBTI 0.5 mrvi 88 1
Leupeptin 10 mg/mI 101 1
Pepstatin A 10 jtg/ml 97 2
EDTA 0.5 mr.t 85 I
1,10-Phenanthroline 1 mM 74 1
E-64 50IM 96±1
E-64d 20 jsM 87 1
Calpain peptide inhibitor 20 /SM 76 1
Fig. 2. Effect of specific caspase inhibitors on the caspase activity in
LLC-PK1 cells. The cell extracts (200 j.g) were preincubated with 50 sM
each of caspase inhibitors I (YVAD-CHO) and II (DEVD-CHO) before
the addition of the caspase substrate, Ac-Tyr-VaI-Ala-Asp-AMC. The
reaction mixture was prepared, incubated for 60 minutes and assayed as
described in the Methods section. Results are mean SE, N = 3.
0,001 compared to control.
pattern of staining for DNA strand breaks, indicating that the
inhibitors afford strong protection against antimycin A-induced
DNA damage. We considered the possibility that the caspase
inhibitors could block the cellular uptake of antimycin A. If this
was the case, then the fall in ATP level induced by antimycin A
would be reduced in the presence of caspase inhibitors. There was
a similar and dramatic fall in ATP levels in the presence of
caspase inhibitors. Cellular ATP declined from 31.0 0.05 to
1.5 0.05 nmol/mg protein in cells treated with antimycin A alone
(N = 2). There was no difference in cellular ATP level between
cells exposed to antimycin A alone and those pretreated with the
caspase inhibitor I (1.5 0.05 nmol/mg protein), or inhibitor II
(1.4 0.05 nmol/mg protein), suggesting that the protective effect
Time of antimycin A treatment, minutes
Fig. 3. Time course effect of antimycin A-induced injury on caspase
activity in LLC-PK1 cells. The caspase activity was determined at various
times of antimycin A exposure as described in the Methods section. The
net increase in caspase activity was obtained by subtracting the values of
control cells from the corresponding values of antimycin A treated cells.
Results are mean sE, N = 3. P < 0.001 compared with control cells.
of caspase inhibitors was not due to the effect on antimycin A
uptake.
Since antimycin A-induced injury to LLC-PK1 cells results in
significant cell death [18], we determined whether caspase inhib-
itors provide protection against antimycin A-induced cell death.
Treatment of cells with the tetrapeptide caspase inhibitors I and II
prevented hypoxia-induced cell death as measured by tiypan blue
exclusion in a dose-dependent manner (Fig. 7A). At 50 p.M
concentration, these inhibitors significantly prevented antimycin
A-induced cell death (control, 6 1%; antimycin A alone, 40
1%; antimycin A + inhibitor I, 16 1%; antimycin A + inhibitor
II, 16 1%; N 4 to 7, P < 0.001, Fig. 7B). We confirmed that
the caspase inhibitors did not prevent the cellular uptake of the
trypan blue dye when added along with the dye (antimycin A
alone, 42 1%; antimycin A + inhibitor I at 50 p.M, 41 2%;
antimycin A + inhibitor II at 50 p.M, 42 1%; N = 3).
DISCUSSION
In the present study we have demonstrated that LLC-PK1
cells contain caspase activity that is not inhibited by inhibitors of
serine proteases (PMSF, aprotinin SBTI), aspartic proteases
(pepstatin A), and metalloproteinases (EDTA, 1,10-phenanthro-
line). Caspase activity is also not inhibited by other cysteine
protease inhibitors including leupeptin, E-64, E64d and a specific
calpain peptide inhibitor. However, this activity is markedly
inhibited by peptide inhibitors of caspase proteases, YVAD-CHO
and DEVD-CHO, indicating the presence of caspases in LLC-
PK1 cells. We have shown that antimycin A treatment results in
rapid increase in caspase activity prior to any evidence of DNA
damage and cell death.
Although most of the recent studies related to hypoxia/reoxy-
genation in vitro and ischemia/reperfusion in vivo injury provide
evidence for internucleosomal DNA fragmentation and endonu-
clease activation, there is no information on the role of caspase
proteases in antimycin A-induced DNA damage in any tissue. In
the present study we have utilized some of the most potent and
Table 1. Effect of proteinase inhibitors on caspase activity
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various amounts of inhibitors before the addition of the substrate. The
incubations were continued for 30 minutes and the liberated AMC
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Fig. 4. (A) Effect of increasing concentration of caspase inhibitors on
antimycin A-induced DNA strand breaks in LLC-PK1 cells. Cells were
preincubated for 60 minutes with increasing concentrations of inhibitor I
or II prior to induction of chemical hypoxia with antimycin A (10 ItM) for
an additional 60 minutes. Residual double stranded DNA was determined
by alkaline unwinding assay as described in the Methods section. Symbols
are: (LI) inhibitor I (YVAD-CHO); (Li) inhibitor II (DEVD-CHO).
Results are mean SE, N = 4. p < 0.001 compared to cells exposed to
antimycin A alone. (B) Effect of caspase inhibitors on antimycin A-in.
duced DNA strand breaks in LLC-PK1 cells. Cells were preincuhated with
50 tM concentration of caspase inhibitor I or inhibitor II for 60 minutes
prior to induction of chemical hypoxia with antimycin A (10 ILM) for an
additional 60 minutes. Results are mean SE, N = 4. P < 0.001
compared to cells exposed to antimycin A alone. Symbols are: (U) control;
(LI) antimycin A alone; (ti) antimycin A + inhibitor I; () antimycin A --
inhibitor II.
reversible competitive inhibitors of caspases, YVAD-CHO and
DEVD-CHO, to investigate the role of caspases in antimycin
A-induced injury. These peptide inhibitors are based on the
cleavage site of aspartic acid and other amino acids required to
the left of the cleavage site [21, 22, 281 for caspases. We have
shown that these cleavage-site directed peptide inhibitors pre-
vented DNA strand breaks as revealed by an alkaline unwinding
assay, and internucleosomal DNA fragmentation revealed by
agarose gel electrophoresis in antimycin A-induced hypoxic injury
to LLC-PK1 cells. In addition, in situ studies based on specific
labeling of DNA breaks in nuclei with TdT and subsequent
immunohistochemical staining of fragmented DNA in cells fur-
ther demonstrate that the peptide inhibitors provide protection
against DNA fragmentation in antimycin A-induced injury. Thus,
the protective effects of the peptide inhibitors strongly suggest the
Fig. 5. Effect of caspase inhibition on antimycin A-induced DNA frag-
mentation. Cells were exposed to antimycin A (10 ILM) for 120 minutes in
the absence and presence of 50 rM caspase inhibitor I (YVAD-CHO).
The fragmented DNA was isolated from each sample and subjected to 1%
agarose gel electrophoresis. Lanes are: (1) molecular size marker, (2)
control, (3) antimycin A alone, (4) antimycin A + caspase inhibitor I. The
data depicted are representative of four experiments.
role of caspases in mediating DNA damage in antimycin A-in-
duced injury. To our knowledge, this is the first report on the
protective effect of caspase protease inhibitors on DNA damage
in chemical hypoxic injury to cells.
The internucleosomal DNA fragmentation observed in antimy-
cm A-induced injury can result from the cleavage of chromatin
proteins (histones and nuclear matrix proteins) followed by
cleavage of exposed DNA by endonucleases. At present it is not
known which nuclear matrix proteins or other protein substrates
are involved in hypoxic/ischemic injury. However, recent studies
have demonstrated that DNA fragmentation observed in apopto-
tic cell death in several mammalian cell lines is accompanied by
the cleavage of several potential target substrates. A number of
target proteins for caspases have been identified including nuclear
lamin subunits [29—31], the nuclear enzyme Poly (ADP-ribose)
polymerase [21, 32, 33] and DNA-dependent protein kinase [34],
both involved in aspects of DNA damage sensing and repair [35,
36], UI small nuclear ribonucleoprotein [37], and actin [38]. In
ischemic or hypoxic injury, caspase proteases may play a funda-
mental role in DNA damage and subsequent cell death presum-
ably through their proteolytic action on proteins essential for
cellular repair and other target proteins, including the proteins
required for the stability of DNA itself.
In parallel studies we also demonstrated that in addition to
prevention of internucleosomal DNA cleavage, caspase inhibitors
protected against cell death in antimycin-induced hypoxic injury
to LLC-PK1 cells in a dose dependent manner. While this work
was in progress, a pertinent study consistent to our results by
Shimuzu et al [19] demonstrated that caspase inhibitors prevented
cell death in rat pheochromocytoma cells (PC12 cells) exposed to
cyanide, rotenone or antimycin A. Thus, it is apparent from these
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Fig. 6. Effect of caspase inhibitors on in situ chemical hypoxia-induced DNA strand breaks in LLC-PK1 cells. Cells were grown to confluence on
two-chamber tissue culture slides. Cells were exposed to antimycin A for 120 minutes in the absence or presence of 50 M caspase inhibitor I or inhibitor
II. The cells were analyzed for in situ DNA strand breaks by terminal deoxynucleotidyl transferase (TdT)/digoxigenin dUTP nick end labeling (TUNEL)
technique as described in the Methods section. (A) Control. (B) Cells treated with antimycin A alone. (C) Cells exposed to antimycin A plus caspase
inhibitor I. (D) Cells exposed to antimycin A plus caspasc inhibitor II.
studies that cell injury induced by inhibition of mitochondrial hypoxic injury. A recent study has shown that calpain activity is
respiratory chain involves the participation of caspases. In addi- increased by 7.5 minutes of hypoxia to proximal tubules and the
tion to caspases, other proteases may also be involved during cysteine protease inhibitor, N-benzyloxycarbonyl-Val-Phe-methyl
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Fig. 7. (A) Dose-dependent effect of caspase inhibitors on antimycin
A-induced cell death in LLC-PK1 cells. Cells were preincubated for 60
minutes with increasing concentrations of inhibitor I or II prior to
induction of chemical hypoxia with antimycin A (10 /LM) for an additional
60 minutes. Cell death was measured by trypan blue exclusion. Symbols
are: (El) inhibitor I; (A) inhibitor II. Results arc mean se, N = 4, *p.(
0.001, compared to cells exposed to antimycin A alone. (B) Effect of
caspase inhibitors on antimycin A-induced cell death in LLC-PK cells.
Cells were preincubated with 50 rM concentration of caspase inhibitor I or
inhibitor II for 60 minutes prior to induction of chemical hypoxia with
antimycin A (10 sM) for an additional 60 minutes. Results are mean SE,
N = 4 to 7; *P < 0.001, compared to cells exposed to antimycin A alone.
Symbols are: (•) control; (Eli) antimycin A alone; (LI) antimycin A +
inhibitor I; () antimycin A + inhibitor II.
In future studies the mechanism(s) of activation of the caspase(s),
the potential targets as well the particular members of the caspase
family involved in these processes will need to be identified.
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